← Back to headlines
India's Generic Copies Impact Eli Lilly's Sales Performance
The proliferation of generic drug copies from India is reportedly having a detrimental effect on the sales figures of pharmaceutical giant Eli Lilly.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
